World Lifestyle Archives | Page 5 of 417 | Be Korea-savvy

Archive by category World Lifestyle

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular Institute of the South successfully treats first patient in the U.S. using Philips’ innovative laser system, marking a milestone in advancing personalized care [...]

18th Global Citizenship Conference to be held in Singapore

18th Global Citizenship Conference to be held in Singapore

LONDON, Nov. 04, 2024 (Korea Bizwire) – More than 400 delegates from over 50 countries are expected to attend the 18th annual Global Citizenship Conference, which takes place 27–29 November in Singapore. Hosted by world-leading international citizenship and residence advisory firm Henley & Partners, this annual event has become the world’s largest and most significant conference on investment migration, [...]

Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition

Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition

IMPACT-TD Registry, the largest study evaluating holistic effects of tardive dyskinesia (TD), highlights that there is a high burden of TD on quality of life regardless of a person’s underlying mental health condition Registry revealed fewer patients with psychotic disorders (36%) received TD diagnoses compared to those with mood disorders (50%) Teva continues to further [...]

Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-’749 (olanzapine) a Subcutaneous Long-Acting Injectable as well as Results of Real-World Analyses of UZEDY® (risperidone)

Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-’749 (olanzapine) a Subcutaneous Long-Acting Injectable as well as Results of Real-World Analyses of UZEDY® (risperidone)

Teva’s presentation of findings from six schizophrenia studies at Psych Congress 2024 highlights its commitment to finding new innovations in neuroscience Data show TEV-’749 drug delivery technology resulted in no occurrence of Post-Injection Delirium/Sedation Syndrome (PDSS) events to date Real-world analyses of UZEDY (risperidone) subcutaneous long-acting injectable reveal high adherence rates and utilization in adults [...]

Sabin Sends More Marburg Vaccines for Rwanda’s Outbreak

Sabin Sends More Marburg Vaccines for Rwanda’s Outbreak

WASHINGTON, Oct. 31 (Korea Bizwire) — In continued collaboration with Rwanda to address the Marburg virus outbreak, the Sabin Vaccine Institute has dispatched approximately 1,000 additional investigational vaccine doses for a randomized clinical trial arm within the ongoing open-label study. More than 1,500 frontline workers have already been vaccinated in Rwanda with the Sabin vaccine. [...]

Samba TV Announces Acquisition of Semasio, Strengthening its Position in Contextual Targeting

Samba TV Announces Acquisition of Semasio, Strengthening its Position in Contextual Targeting

Strategic Acquisition Deepens Samba TV’s Agency and Platform Partnerships and Expands Global Footprint With Semantic Analysis of the Open Web SAN FRANCISCO, Oct. 31, 2024 (Korea Bizwire) – Samba TV, the leading provider of TV technology for audience data and omniscreen measurement, today announced its acquisition of Semasio, a global provider of contextual targeting and [...]

Sandoz reports third-quarter and nine-month 2024 sales

Sandoz reports third-quarter and nine-month 2024 sales

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Strong third-quarter biosimilars growth of 37% in constant currencies from existing portfolio and recent launches Generics growth acceleration driven by Europe Third-quarter net sales¹ of USD 2.6 billion, up 12% in constant currencies (up 11% in USD) Nine-month net sales of USD 7.6 billion, [...]

Ardena Expands Bioanalytical Services in Europe

Ardena Expands Bioanalytical Services in Europe

GHENT, Belgium, Oct. 29, 2024 (Korea Bizwire) —  Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlands and Sweden, today announced a substantial expansion of its Bioanalytical Services in the Netherlands. This strategic investment includes establishing a brand new bioanalytical lab at Ardena’s Pivot Park facility [...]

Captivision Announces Venture at Dream Hollywood Hotel

Captivision Announces Venture at Dream Hollywood Hotel

Innovative Digital Out-of-Home Media, Catalyzing New Revenue Streams MIAMI and SEOUL, Korea, Oct. 29, 2024 (Korea Bizwire) – Captivision Inc. (“Captivision” or the “Company”) (Nasdaq: CAPT), a pioneer manufacturer of architectural media glass and innovative LED solution provider, today announced its first collaboration with the Dream Hollywood hotel in Los Angeles. Crescent Hotels & Resorts, a leading hotel [...]